Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...
Astria Therapeutics initiated with an Outperform at JMP Securities
JMP Securities analyst Jonathan Wolleben initiated coverage of Astria Therapeutics (ATXS) with an Outperform rating and $26 price target ...
JMP Securities Keeps Their Buy Rating on LPL Financial (LPLA)
JMP Securities analyst Devin Ryan reiterated a Buy rating on LPL Financial (LPLA – Research Report) today and set a price target of $435.00.
JMP reiterates Kalvista stock with $19 target, sees market growth
JMP Securities maintained a positive outlook on Kalvista Pharmaceuticals Inc (NASDAQ:KALV), reiterating a Market Outperform ...
JMP Securities starts Astria Therapeutics stock at Market Outperform
JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a ...
Orchid Island Capital, Inc. (ORC) Q4 2024 Earnings Call Transcript
Good morning, and welcome to the Fourth Quarter 2024 Earnings Conference Call for Orchid Island Capital. This call is being recorded today, January 31, 2025.
bovnews22h
What’s Behind the -4.69% Drop in Sana Biotechnology Inc (SANA) Stock? Find Out Now!
Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $3.25 which represents a decrease of $-0.16 or -4.69% from the prior close of $3.41. The stock opened at $3.4 and touched a low of ...